id
stringclasses 2
values | status
stringclasses 1
value | _server_id
stringclasses 2
values | image
imagewidth (px) 556
4.59k
| caption-1
stringclasses 2
values | caption-2
stringclasses 2
values | caption_1_model
stringclasses 1
value | caption_2_model
stringclasses 1
value | Original_Filename
stringclasses 2
values | ranking.responses.users
sequencelengths 1
1
| ranking.responses
sequencelengths 1
1
| ranking.responses.status
sequencelengths 1
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|
2144bab0-2fcb-4a5a-b999-23bef1fccebf | completed | d8242762-aa66-4d14-85df-f9a929581fdb | The image is a screenshot of a document titled "Study Topic: EXALGO Use in the Clinical Setting". The document is divided into two sections. The top section has a white background with a pattern of small black dots. Below the pattern, there is a blue header with the text "Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain". The bottom section has the Exalgo logo in blue and white. The text is written in black font and is centered on the page. | The image is a white page with a blue logo in the bottom right corner. The text on the page is written in black and pink, and it discusses study results comparing Exalgo's drug to placebo in clinical trials for treating pain associated with osteoarthritis of the knee. | microsoft/Florence-2-large | internlm/internlm-xcomposer2-7b | 023443f2-a838-4684-9d47-0d5d0711ecae.png | [
"4be3ef12-d9b9-4df4-abf2-c7457f0d070d"
] | [
[
"caption-1",
"caption-2"
]
] | [
"submitted"
] |
|
57211611-42c7-48dd-b871-f4651d39f357 | completed | 3b324b20-5931-4e61-ab15-02f557a8cdfe | The image is a slide from a report titled "Patients on Once-Daily Exalgo Reported Significant Relief from Chronic Pain". The slide is divided into two sections. On the left side of the slide, there is a blue background with white text. The title of the report is written in large, bold font and is centered on the slide. Below the title, there are two bullet points that explain the report.
The first bullet point explains that in multiple clinical studies, patients on one-day EXALGO reported significant relief from chronic pain. It states that the report was published in a study that shows that the patient's condition was experiencing a significant decrease in the number of patients who have been diagnosed with chronic pain in the past few years. The second bullet point shows a bar graph that shows the percentage of patients that have experienced chronic pain, with the highest percentage being in the first quarter of the year and the lowest percentage in the second quarter. The graph also shows a percentage of the patient who experienced chronic fatigue in the third quarter. | The image is a page from a scientific journal, with the title "Patents on Once-Daily Bicalgo reported significant relief from chronic pain" in white text at the top. The background is blue and white, with various graphs and charts depicting data related to the study. There are also several paragraphs of text detailing the results and implications of the research. | microsoft/Florence-2-large | internlm/internlm-xcomposer2-7b | 06a19172-cd80-4a51-99e2-9f96b241d280.png | [
"4be3ef12-d9b9-4df4-abf2-c7457f0d070d"
] | [
[
"caption-1",
"caption-2"
]
] | [
"submitted"
] |